174 related articles for article (PubMed ID: 29287218)
21. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
Kikuchi H; Kanda E; Mandai S; Akazawa M; Iimori S; Oi K; Naito S; Noda Y; Toda T; Tamura T; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):55-62. PubMed ID: 26920126
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults.
Lim CC; Teo BW; Tai ES; Lim SC; Chan CM; Sethi S; Wong TY; Sabanayagam C
PLoS One; 2015; 10(3):e0122009. PubMed ID: 25793395
[TBL] [Abstract][Full Text] [Related]
23. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation.
Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M
J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474
[TBL] [Abstract][Full Text] [Related]
24. Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study.
Yamamoto T; Miyazaki M; Nakayama M; Yamada G; Matsushima M; Sato M; Sato T; Taguma Y; Sato H; Ito S
Clin Exp Nephrol; 2016 Aug; 20(4):595-602. PubMed ID: 26519375
[TBL] [Abstract][Full Text] [Related]
25. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
26. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
[TBL] [Abstract][Full Text] [Related]
27. Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.
Niihata K; Tomosugi N; Uehata T; Shoji T; Mitsumoto K; Shimizu M; Kawabata H; Sakaguchi Y; Suzuki A; Hayashi T; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Dec; 27(12):4378-85; discussion 4384-5. PubMed ID: 22833619
[TBL] [Abstract][Full Text] [Related]
28. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
29. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
30. Total and HMW adiponectin is independently associated with B-type natriuretic peptide and anemia in chronic hemodialysis patients.
Abe Y; Matsumae T; Eto S; Watanabe M; Ito K; Sasatomi Y; Ogahara S; Nakashima H; Saito T
Intern Med; 2012; 51(23):3247-52. PubMed ID: 23207119
[TBL] [Abstract][Full Text] [Related]
31. Anemia and risk for cognitive decline in chronic kidney disease.
Kurella Tamura M; Vittinghoff E; Yang J; Go AS; Seliger SL; Kusek JW; Lash J; Cohen DL; Simon J; Batuman V; Ordonez J; Makos G; Yaffe K
BMC Nephrol; 2016 Jan; 17():13. PubMed ID: 26823182
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
[TBL] [Abstract][Full Text] [Related]
33. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
34. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
[TBL] [Abstract][Full Text] [Related]
35. Synergetic Association between Anemia and Hyperuricemia on New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study.
Chen YC; Liu YH; Wu PY; Huang JC; Su HM; Chen SC; Chang JM
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674173
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus.
Yun JS; Ahn YB; Song KH; Yoo KD; Park YM; Kim HW; Ko SH
Diabet Med; 2016 May; 33(5):639-43. PubMed ID: 26202453
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
[TBL] [Abstract][Full Text] [Related]
38. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
[TBL] [Abstract][Full Text] [Related]
39. Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.
Tran L; Batech M; Rhee CM; Streja E; Kalantar-Zadeh K; Jacobsen SJ; Sim JJ
Nephrol Dial Transplant; 2016 Apr; 31(4):636-45. PubMed ID: 26254460
[TBL] [Abstract][Full Text] [Related]
40. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
